Metropolitan Life Insurance Company (MetLife)’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-14,520
Closed -$3.13M 450
2024
Q1
$3.13M Sell
14,520
-133
-0.9% -$27.9K 0.14% 133
2023
Q4
$3.09M Sell
14,653
-231
-2% -$49.3K 0.15% 124
2023
Q3
$2.98M Sell
14,884
-792
-5% -$157K 0.15% 119
2023
Q2
$2.9M Sell
15,676
-413
-3% -$76.3K 0.14% 126
2023
Q1
$3.08M Sell
16,089
-4,718
-23% -$853K 0.16% 118
2022
Q4
$3.5M Sell
20,807
-592
-3% -$103K 0.16% 128
2022
Q3
$3.79M Sell
21,399
-250
-1% -$49.4K 0.18% 114
2022
Q2
$4.43M Sell
21,649
-529
-2% -$112K 0.19% 104
2022
Q1
$5.28M Sell
22,178
-18,890
-46% -$4.44M 0.19% 104
2021
Q4
$9.38M Sell
41,068
-1,165
-3% -$256K 0.13% 124
2021
Q3
$8.17M Sell
42,233
-1,431
-3% -$290K 0.12% 139
2021
Q2
$9.29M Sell
43,664
-608
-1% -$128K 0.13% 123
2021
Q1
$9.04M Sell
44,272
-2,187
-5% -$431K 0.14% 126
2020
Q4
$8.46M Sell
46,459
-1,871
-4% -$318K 0.13% 133
2020
Q3
$8.09M Sell
48,330
-2,157
-4% -$363K 0.14% 129
2020
Q2
$8.21M Sell
50,487
-3,114
-6% -$558K 0.15% 123
2020
Q1
$9.27M Sell
53,601
-207
-0.4% -$41.2K 0.19% 99
2019
Q4
$10.8M Sell
53,808
-360
-0.7% -$73.9K 0.17% 103
2019
Q3
$11.4M Sell
54,168
-1,845
-3% -$385K 0.19% 93
2019
Q2
$10.9M Buy
56,013
+3,355
+6% +$618K 0.18% 93
2019
Q1
$8.67M Sell
52,658
-1,401
-3% -$248K 0.16% 111
2018
Q4
$10.2M Buy
54,059
+3,436
+7% +$635K 0.2% 82
2018
Q3
$8.62M Sell
50,623
-1,825
-3% -$307K 0.15% 122
2018
Q2
$8.6M Buy
52,448
+87
+0.2% +$14.2K 0.14% 132
2018
Q1
$8.47M Buy
52,361
+329
+0.6% +$52.4K 0.12% 130
2017
Q4
$7.6M Sell
52,032
-108,676
-68% -$15.5M 0.1% 152
2017
Q3
$21.8M Sell
160,708
-2,858
-2% -$361K 0.14% 132
2017
Q2
$20.5M Sell
163,566
-4,337
-3% -$519K 0.14% 135
2017
Q1
$19.9M Sell
167,903
-2,398
-1% -$288K 0.14% 137
2016
Q4
$19.6M Sell
170,301
-4,216
-2% -$469K 0.14% 134
2016
Q3
$18.2M Sell
174,517
-1,148
-0.7% -$120K 0.13% 144
2016
Q2
$17.1M Sell
175,665
-1,138
-0.6% -$108K 0.13% 148
2016
Q1
$17M Sell
176,803
-3,073
-2% -$280K 0.13% 145
2015
Q4
$16.3M Sell
179,876
-4,513
-2% -$425K 0.13% 155
2015
Q3
$17.1M Buy
184,389
+7,446
+4% +$708K 0.12% 155
2015
Q2
$16.5M Sell
176,943
-1,296
-0.7% -$121K 0.12% 172
2015
Q1
$16.9M Sell
178,239
-2,055
-1% -$190K 0.12% 167
2014
Q4
$16M Sell
180,294
-938
-0.5% -$79.5K 0.11% 180
2014
Q3
$14.5M Sell
181,232
-2,494
-1% -$188K 0.1% 195
2014
Q2
$13M Sell
183,726
-8,892
-5% -$626K 0.09% 232
2014
Q1
$14.3M Sell
192,618
-2,760
-1% -$208K 0.1% 204
2013
Q4
$15.3M Sell
195,378
-3,381
-2% -$265K 0.11% 186
2013
Q3
$14.7M Buy
198,759
+3,264
+2% +$240K 0.11% 182
2013
Q2
$14.9M Buy
+195,495
New +$12.8M 0.12% 165

Other funds holding CME

Metropolitan Life Insurance Company (MetLife)'s CME Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of CME Group (CME) in Q2 2024, closing a stake of 14,520 shares — an estimated $3.13M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CME in Q2 2013 and held it in 44 quarters. The position peaked at $21.8M in Q3 2017. 1,379 funds tracked by Wall St. Rank hold CME as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining CME Group position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 14,520 CME Group shares in Q2 2024, an estimated $3.13M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in CME Group in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s CME Group position peaked at $21.8M in Q3 2017.
  • 1,379 funds tracked by Wall St. Rank held CME Group as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.